ThioTEPA

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:ThioTEPA.svg
ThioTEPA
Systematic (IUPAC) name
N,N ' N '-triethylenethiophosphoramide
Identifiers
CAS number 52-24-4
ATC code L01AC01
PubChem 5453
Chemical data
Formula C6H12N3PS 
Mol. mass 189.219 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic (CYP2B6, CYP2C11)
Half life 2.4 hours
15-18 hours (metabolites)
Excretion Renal
Therapeutic considerations
Pregnancy cat.

D(AU) D(US)

Legal status

POM(UK) -only(US)

Routes IV, intracavitary, intravesical

WikiDoc Resources for

ThioTEPA

Articles

Most recent articles on ThioTEPA

Most cited articles on ThioTEPA

Review articles on ThioTEPA

Articles on ThioTEPA in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ThioTEPA

Images of ThioTEPA

Photos of ThioTEPA

Podcasts & MP3s on ThioTEPA

Videos on ThioTEPA

Evidence Based Medicine

Cochrane Collaboration on ThioTEPA

Bandolier on ThioTEPA

TRIP on ThioTEPA

Clinical Trials

Ongoing Trials on ThioTEPA at Clinical Trials.gov

Trial results on ThioTEPA

Clinical Trials on ThioTEPA at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ThioTEPA

NICE Guidance on ThioTEPA

NHS PRODIGY Guidance

FDA on ThioTEPA

CDC on ThioTEPA

Books

Books on ThioTEPA

News

ThioTEPA in the news

Be alerted to news on ThioTEPA

News trends on ThioTEPA

Commentary

Blogs on ThioTEPA

Definitions

Definitions of ThioTEPA

Patient Resources / Community

Patient resources on ThioTEPA

Discussion groups on ThioTEPA

Patient Handouts on ThioTEPA

Directions to Hospitals Treating ThioTEPA

Risk calculators and risk factors for ThioTEPA

Healthcare Provider Resources

Symptoms of ThioTEPA

Causes & Risk Factors for ThioTEPA

Diagnostic studies for ThioTEPA

Treatment of ThioTEPA

Continuing Medical Education (CME)

CME Programs on ThioTEPA

International

ThioTEPA en Espanol

ThioTEPA en Francais

Businness

ThioTEPA in the Marketplace

Patents on ThioTEPA

Experimental / Informatics

List of terms related to ThioTEPA

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression.

References

  • Sykes M et al. (1953). "Clinical Studies of triethylenephosphoramide compounds with nitrogen mustard-like activity". Cancer 6: 142-48.
  • Maanen MJ, Smeets CJ, Beijnen JH (2000). "Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA)". Cancer Treat Rev 26 (4): 257-68. PMID 10913381.

de:Thiotepa

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
related articles
viewed previously [ + ]